Cranioplasty Cognitive Outcome Study

October 15, 2019 updated by: Peter Woo Yat Ming, Kwong Wah Hospital

Impact of Cranioplasty on Cognitive Outcome: A Multi-Center Prospective Randomized Study

This will be a multicenter prospective randomized study of adult patients with an acquired skull defect as a result of craniectomy and considered suitable for cranioplasty, i.e. reconstruction of the skull defect, at all seven Hong Kong Hospital Authority neurosurgical units. Patients that underwent their primary craniectomy operation at any of the Hospital Authority neurosurgery centers from the 1st March 2019 and considered suitable for cranioplasty will be included in this study. Those who underwent their primary craniectomy before 1st March 2019 or at an institution other than the aforementioned neurosurgical units will be excluded. Data from clinical records, operation notes, medication-dispensing records, laboratory records and radiological reports will be collected.

30 adult patients with craniectomy will be recruited and randomized into two groups: "early" cranioplasty, i.e. performed within 3 months of craniectomy, and "late", i.e. cranioplasty performed more than 3 months after the operation. The aim of the study is to determine whether early cranioplasty can improve on patient's cognitive performance compared to those who undergo the procedure after 3 months.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Decompressive craniectomy, a neurosurgical procedure where a portion of the skull calvarium is removed, is a life-saving procedure. The complication rate of cranioplasty, a neurosurgical procedure where the acquired skull defect is reconstructed, ranges from 11% to 26% and includes postoperative hemorrhage and infection. (4) The syndrome of the trephined is a recognized long-term complication in which certain groups of patients, experience debilitating neurocognitive deficits in addition to chronic headache, dizziness, fatigability and clinical depression. (2) It is believed that the lack of an overlying bone may cause undue significant atmospheric pressure on the underlying cortex, thereby reducing cerebral perfusion and cerebrospinal fluid flow. There are reports that cognitive improvement can be observed in up to 30% of patients after cranioplasty yet the underlying mechanism for this observation is unclear. (1) Some studies have demonstrated enhanced cerebral perfusion by non-invasive investigations, but there is a lack of large scale systematically performed studies to verify such cerebral hemodynamic effects. (1-3) Clinical equipoise exists regarding the optimum timing of cranioplasty procedures after craniectomies. While the anecdotal practice of delaying cranioplasty for at least 3 months after a craniectomy is common, local and overseas observational studies suggest that performing early cranioplasties (i.e. within 3 months) is equally safe in terms of infection and other operative complications. (4-6)

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Hong Kong
      • Hong Kong, Hong Kong, China
        • Recruiting
        • Kwong Wah Hospital
        • Principal Investigator:
          • Peter YM Woo, FRCS (SN)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age greater than or equal to 18 years-old,
  2. Craniectomy was performed due to head injury, infarct or spontaneous intracerebral hemorrhage, and benign tumors.
  3. Craniectomy skull defect size of >10cm at its longest diameter
  4. Craniectomy performed at any of the Hospital Authority's Neurosurgical Centers after 1st March 2019

Exclusion Criteria:

  1. Age older than 80 years-old,
  2. Patients cannot communicate by obeying simple command,
  3. Patients who are unfit for cranioplasty as decided by the treating neurosurgeon
  4. Posterior fossa craniectomy
  5. Craniectomy performed before 1st March 2019
  6. Craniectomy performed at an institution outside the Hospital Authority
  7. Any pre-existing illness that renders the patient moderately or severely disabled before the brain insult.
  8. Patients that need an additional procedure e.g. cerebrospinal fluid shunting with cranioplasty in the same setting.
  9. History of central nervous system infection
  10. Craniectomy-related complications such as hemorrhage or surgical site infection requiring surgical intervention or deemed to affect patient's long-term cognitive outcome
  11. Claustrophobia or any other medical condition that prohibits the patient from undergo MRI scanning
  12. Patients who cannot understand spoken English or Chinese

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: "Late" cranioplasty
Subjects undergoing cranioplasty within 3 months after craniectomy.
Experimental: "Early" cranioplasty
Subjects undergoing cranioplasty beyond 3 months after craniectomy.
Subjects undergoing cranioplasty beyond 3 months after craniectomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Montreal Cognitive Assessment (MOCA)
Time Frame: 3-months
Minimum (worse): 0/30; Maximum (best) 30/30. Higher values represent a better outcome.
3-months
Neurobehavioural Cognitive State Examination (NCSE)
Time Frame: 3-months
Multi-domain assessment involving: orientation, attention, registration, comprehension, repetition, naming, construction, calculation, similarities,judgement. Stratification of each domain into mild, moderate and severe impairment. The higher the number the better the outcome.
3-months
Rivermead Behavioural Memory Test (RBMT)
Time Frame: 3-months
3-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor assessment
Time Frame: 3-months
Medical Research Council limb power
3-months
Modified Functional Ambulation Category (MFAC)
Time Frame: 3-months
7 ordinal scale assessment. The lower the scale, the worse the ambulatory ability of the patient. I: bed bound; 2: wheel-chair bound; 3: dependent walker; 4: Assisted walker; 5: Supervised walker; 6: Indoor walker; 7: Outdoor walker (patient can walk anywhere).
3-months
Quality of life assessment
Time Frame: 3-months
Short Form-36 (SF-36)
3-months
Psychological assessment
Time Frame: 3-months
Beck depression inventory (BDI)
3-months
Caregiver assessment
Time Frame: 3-months
Caregiver Strain Index
3-months
Caregiver
Time Frame: 3-months
Caregiver self-assessment questionnaire
3-months
MRI cerebral perfusion assessment
Time Frame: 3-months
Cerebral blood flow
3-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Anticipated)

September 1, 2020

Study Completion (Anticipated)

March 1, 2021

Study Registration Dates

First Submitted

December 30, 2018

First Submitted That Met QC Criteria

December 30, 2018

First Posted (Actual)

January 3, 2019

Study Record Updates

Last Update Posted (Actual)

October 17, 2019

Last Update Submitted That Met QC Criteria

October 15, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on "Early" cranioplasty

3
Subscribe